• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激肽释放酶治疗特发性少精子症:一项双盲研究的结果

Treatment of idiopathic oligozoospermia by kallikrein: results of a double-blind study.

作者信息

Schill W B

出版信息

Arch Androl. 1979 Mar;2(2):163-70. doi: 10.3109/01485017908987308.

DOI:10.3109/01485017908987308
PMID:573602
Abstract

Ninety subfertile men with idiopathic oligozoospermia were treated orally with either 600 units porcine pancreatic kallikrein or placebo daily for 7 wk. Kallikrein caused an increase in the number of spermatozoa (3.1 X 10(7) with a maximum 2--3 mo after onset of therapy. There was an improvement of the quantitative and qualitative sperm motility with a maximum at the end of treatment. Five months after onset of therapy, pretreatment values were regained. There were no major side effects. Conception rates within a period of 1 yr were 16% for placebo and 38% for kallikrein.

摘要

90名患有特发性少精子症的不育男性每天口服600单位猪胰激肽释放酶或安慰剂,持续7周。激肽释放酶使精子数量增加(治疗开始后最多2 - 3个月时为3.1×10⁷)。治疗结束时精子活力在数量和质量上都有改善且达到最大值。治疗开始5个月后,恢复到治疗前水平。没有严重副作用。1年内安慰剂组的受孕率为16%,激肽释放酶组为38%。

相似文献

1
Treatment of idiopathic oligozoospermia by kallikrein: results of a double-blind study.激肽释放酶治疗特发性少精子症:一项双盲研究的结果
Arch Androl. 1979 Mar;2(2):163-70. doi: 10.3109/01485017908987308.
2
[First results of parenteral treatment of male fertility disorders using kallikrein: oligozoospermia].
Hautarzt. 1975 Oct;26(10):541-2.
3
[Kallikrein in a double-blind study in idiopathic oligozoospermia].
Hautarzt. 1978 Jun;29(6):319-22.
4
Efficacy of kallikrein in the treatment of oligozoospermia and asthenozoospermia: a double-blind trial.激肽释放酶治疗少精子症和弱精子症的疗效:一项双盲试验。
Fertil Steril. 1993 Dec;60(6):1052-6.
5
The treatment of male subfertility with kallikrein.用激肽释放酶治疗男性生育力低下
Andrologia. 1984 Mar-Apr;16(2):156-61. doi: 10.1111/j.1439-0272.1984.tb00256.x.
6
Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility.激肽释放酶对男性生殖系统的影响及其在治疗伴有活力受损的特发性少精子症中的应用。
Andrologia. 1987 Jun;19 Spec No:238-41. doi: 10.1111/j.1439-0272.1987.tb02339.x.
7
Treatment of men with oligoasthenozoospermia and asthenozoospermia with kallikrein.用激肽释放酶治疗少弱精子症和弱精子症男性。
Acta Eur Fertil. 1985 Jan-Feb;16(1):51-4.
8
[Therapeutic application of kallikrein in idiopathic oligo- and asthenozoospermia (author's transl)].激肽释放酶在特发性少精子症和弱精子症中的治疗应用(作者译)
Wien Med Wochenschr. 1981 Aug 31;131(15-16):401-3.
9
Determination of various semen parameters and sex hormone levels in subfertile men during kallikrein therapy.
Adv Exp Med Biol. 1979;120A:537-46. doi: 10.1007/978-1-4757-0926-1_49.
10
Evaluation of semen quality following kallikrein treatment.激肽释放酶治疗后精液质量评估。
Gynecol Obstet Invest. 1978;9(2-3):132-8. doi: 10.1159/000300976.

引用本文的文献

1
Empirical Treatments for Male Infertility: A Focus on Lifestyle Modifications and Medicines.男性不育的经验性治疗:聚焦生活方式调整与药物治疗
Diseases. 2024 Sep 11;12(9):209. doi: 10.3390/diseases12090209.
2
Advances in the evaluation and treatment of the infertile man.男性不育症评估与治疗的进展
World J Urol. 1997;15(6):378-93. doi: 10.1007/BF01300187.
3
Treatment of male fertility disturbances. Current concepts.
Drugs. 1984 Sep;28(3):263-80. doi: 10.2165/00003495-198428030-00003.
4
Guidelines for drug treatment of male infertility.男性不育症药物治疗指南。
Drugs. 1991 Jan;41(1):60-8. doi: 10.2165/00003495-199141010-00006.